ArticleDiscover oncology2024

Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches.

Prasanna Srinivasan Ramalingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.